Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac safety study of ibogaine with psychotherapy for cocaine and crack dependence
RBR-9zpc27Phase 3Not yet recruiting
- Sponsor
- VeraCruz Brasil
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ibogaine in cocaine use disorder (CUD), sponsored by VeraCruz Brasil. Primary endpoint: Cardiac safety. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
ibogaine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on RBR-9zpc27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9zpc27.